| European Case Law Identifier: | ECLI:EP:BA:2014:T235010.20140520 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 20 May 2014 | ||||||||
| Case number: | T 2350/10 | ||||||||
| Application number: | 04713111.5 | ||||||||
| IPC class: | G01N 33/68 G01N 33/94 G01N 33/50 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | QUANTIFICATION OF BOTULINUM TOXIN | ||||||||
| Applicant name: | Ipsen Biopharm Limited | ||||||||
| Opponent name: | Merz Pharma GmbH & Co. KGaA | ||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Amendments - added subject-matter (yes) | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t102350eu1.html
Date retrieved: 17 May 2021